Search NLS News

The development of Copenhagen Science City started during the financial crisis, 2007-2008, when the Danish government wanted to help reduce unemployment and get some power back into the economy, describes Kristoffer Klebak, Head of Secretariat of Copenhagen Science City at the University of Copenhagen. “We saw some big investments in buildings in the area of the […]

The investment, in the form of an expansion, is a capacity-enhancing measure in the facility that creates space to produce more drugs and vaccines. Prior to the opening of the multi-production facility in 2009, Pfizer invested 1.5 billion SEK and has since made several investments of over half a billion kroner to expand production capacity […]

Calquence, a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in China for the treatment of adult patients with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) who have received at least one prior therapy. “Today’s approval is another step towards our goal of making Calquence available to as many patients […]

Ascelia Pharma has announced a significant organizational reduction following the early August announcement that a re-evaluation of SPARKLE images is required for reaching headline results of the study with the liver imaging candidate drug Orviglance. This immediate action has been taken to reduce costs, states the company. 12 employees will leave the company “As a […]

Cyxone is revising its previous strategy due to important patent grants and valuable market opportunities. During 2023 a range of new biosimilar disease modifying anti-rheumatic drugs (DMARDs), approved by the US Food and Drug Administration, FDA, have been broadly introduced to the American market. As a result, patients with moderate to severe rheumatoid arthritis that […]

Evaxion Biotech has hired Christian Kanstrup as their new Chief Executive Officer. “We believe that Christian’s qualifications and experiences are quite unique within leadership, strategy development and execution and this makes him the perfect candidate to further develop and execute on our AI-based target discovery models ensuring the right pipeline, the right partners but also […]

CDMO Biovian has announced a major investment to expand its manufacturing facility in Turku, Finland. The new facility will cover an area of 6,400 sqm and house cutting-edge equipment and advanced technologies to support the development, manufacturing, and testing of ATMP (Advanced Therapy Medicinal Products), such as adenoviral and AAV (adeno-associated viral) therapies. It will […]

Finnish Bioindustries long-term director Carmela Kantor-Aaltonen is retiring in August 2023 and Alexandra Peth has been appointed as her successor in a Managing Director role starting on August 1st, 2023. “Alexandra’s knowledge of sustainability and green transition will bring new possibilities to Finnish Bioindustries that will strengthen the voice of biotech industry and drive the […]

LEO Pharma has signed an agreement to acquire US-listed Timber Pharmaceuticals. Upon closing, this transaction will add an attractive late-stage asset to LEO Pharma’s pipeline in medical dermatology, the company states. “Signing an agreement to acquire Timber Pharmaceuticals and TMB-001, which is still subject to certain closing conditions, is an additional step in delivering on […]

The former CEO of NorthX Biologics has been appointed CEO and Partner of Haeger & Carlsson (H&C). The company’s mission is to become the leading player in executive search and interim life science in the Nordics and Helena Strigård will lead this expansion, the company states. “With the recruitment of Helena Strigård as the new […]